Senate Hearing Highlights Controversial Claims on mRNA COVID Vaccines

Original: 'Blood clots surge like never before...': McCullough exposes mRNA COVID vaccine lies at Senate hearing

The Economic Times•Apr 6, 20261 min

In a Nutshell

During a U.S. Senate hearing, Dr. Peter McCullough claimed that mRNA COVID vaccines were likely responsible for 73.9% of post-vaccine deaths examined in a recent autopsy series. The hearing, which included testimony from various medical experts, focused on the alleged downplaying of adverse events linked to COVID-19 vaccines.

Key Points

01Dr. Peter McCullough claimed mRNA vaccines linked to 73.9% of post-vaccine deaths in autopsy series.
02The hearing aimed to address concerns about myocarditis and other adverse events from COVID-19 vaccines.
03Various experts and legal voices testified, raising significant debate within the medical community.
04The Senate's Permanent Subcommittee on Investigations organized the hearing to probe federal health agencies' transparency.
05The discussion has intensified scrutiny on vaccine safety and the communication of potential risks.

In-Article Ad

Full Summary

The U.S. Senate’s Permanent Subcommittee on Investigations convened a hearing titled 'The Corruption of Science and Federal Health Agencies,' focusing on the alleged suppression of information regarding adverse events associated with COVID-19 vaccines. Dr. Peter McCullough, a prominent cardiologist, presented findings from a comprehensive autopsy series, asserting that 73.9% of deaths following vaccination were likely linked to mRNA COVID vaccines. This assertion has ignited considerable debate among medical professionals regarding the safety and transparency of vaccine communications. Other experts, including Dr. Jordan Vaughn, Dr. James Thorp, and Attorney Aaron Siri, also provided testimony, emphasizing the need for greater scrutiny of health agencies' handling of vaccine-related adverse events. The hearing reflects growing concerns about vaccine safety and the need for transparent discussions about potential risks.

Key Figures